Through activating the Wnt/β-catenin pathway, the expression of PTEN regulates the levels of Wnt3a, β-catenin, TCF-4, c-Myc, and cyclin D1 to inhibit the viability and motility of AP cells. The gene discussed is WNT3A; the disease is alkaline phosphatase measurement.